title: The risk of recurrent cardiovascular events in patients with increased plasma homocysteine levels is reduced by short but not long-term therapy with folate and B vitamins.
authors.affiliation: Thrombosis/Haemostasis and Haematology Unit, University Hospital of Palermo, Italy. sergio.siragusa@unipa.it
authors.forename: Sergio
authors.initials: S
authors.lastname: Siragusa
authors.forename: Alessandra
authors.initials: A
authors.lastname: Malato
authors.forename: Valeria
authors.initials: V
authors.lastname: Cigna
authors.forename: Raffaela
authors.initials: R
authors.lastname: Anastasio
authors.forename: Lucio Lo
authors.initials: LL
authors.lastname: Coco
authors.forename: Alessandra
authors.initials: A
authors.lastname: Casuccio
authors.forename: Marcello
authors.initials: M
authors.lastname: Ciaccio
mesh_terms: D000368:Aged; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D005260:Female; D005492:Folic Acid / Q000627:therapeutic use*; D006710:Homocysteine / Q000097:blood*; D006801:Humans; D020138:Hyperhomocysteinemia / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome; D014803:Vitamin B Complex / Q000627:therapeutic use*
chemical_list: D006710:Homocysteine; D014803:Vitamin B Complex; D005492:Folic Acid